Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intra-Articular Dexmedetomidine: A Treatment for Chronic Knee Pain
Sponsor: Tanta University
Summary
Chronic knee osteoarthritis (KOA) is a painful condition with limited treatment options. Non-pharmacological approaches often fall short, leading to decreased quality of life. Ozone therapy, a simple and affordable treatment, has shown promise for pain relief. Dexmedetomidine (DEX), a sedative and analgesic, has been used successfully as an adjuvant to anesthesia and local anesthetics. Given its potential for pain management, exploring DEX as a treatment for KOA could offer a new and promising approach.
Official title: Intra-articular Dexmedetomidine for Treatment of Chronic Knee Pain: A Prospective Case-Control Clinical Trial
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2024-09-17
Completion Date
2025-03
Last Updated
2024-10-15
Healthy Volunteers
No
Conditions
Interventions
Triamcinolone Acetonide
1 ml of triamcinolone acetonide was used to prepare a solution for knee injection for patients with Chronic Knee Pain
Bupivacaine Hydrochloride
20mg of bupivacaine hydrochloride was used to prepare a solution for knee injection for patients with Chronic Knee Pain
Dexmedetomidine
Dexmedetomidine solution was prepared by mixing Dexmedetomidine in a dose of 3 µg/kg in 5-ml saline
Locations (1)
Tanta University
Tanta, El Gharbyia, Egypt